Project Impact: A Culturally-Tailored Adherence Intervention for Latino Smokers
NCT ID: NCT01811628
Last Updated: 2017-07-18
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
26 participants
OBSERVATIONAL
2013-07-17
2017-07-14
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Project Impact 2: A Culturally Tailored Smoking Cessation Intervention for Latino Smokers
NCT02596711
Determinants of Smoking Cessation Among Latinos
NCT01008748
Mobile Smoking Treatment for Hispanic Individuals Who Smoke
NCT06586034
Mobile Smoking Treatment for Spanish-speaking Latinx Smokers
NCT04417075
Ethnic Microaggressions and Smoking Behaviors Among Latinx Adults
NCT05490927
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
After participant completes this questionnaire, they will be interviewed by a researcher. During this interview participant will be asked to discuss a variety of topics related to smoking and quitting, such as their experience with attempts to quit smoking and problems they may have had. This interview will last about 1 hour.
The interview will be audio-recorded. Participant's interview answers will later be transcribed (written down) without their name or any other identifying information.
Study participation will be complete after the interview.
This is an investigational study.
Up to 48 people will be enrolled in this study. All will take part at MD Anderson.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_ONLY
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Questionnaire + Interview
Latinos and Hispanics who are smokers and recent quitters.
Questionnaire
Questionnaire completion taking about 10-15 minutes.
Interview
Audio-recorded interview that will last about 1 hour.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Questionnaire
Questionnaire completion taking about 10-15 minutes.
Interview
Audio-recorded interview that will last about 1 hour.
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. Current smoker (\>10 cigarettes per day for the past 3 months) or recently quit Smoking (within the past year) but has not smoked for the past 2 months)
3. Read, understand and speak Spanish
4. Identify as being of Latino (or Hispanic) heritage, ethnicity, or ancestry.
Exclusion Criteria
2. The self-report of a diagnosis of a Substance Dependence Disorder other than Nicotine in the past year (i.e., Alcohol Dependence, Amphetamine Dependence, Cannabis Dependence, Cocaine Dependence, Hallucinogen Dependence, Inhalant Dependence, Opioid Dependence, Phencyclidine Dependence, Sedatives, Hypnotics, or Anxiolytic Dependence, or Polysubstance Dependence)
3. Unavailable for a 1.5 hour visit to MD Anderson Cancer Center.
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
National Cancer Institute (NCI)
NIH
M.D. Anderson Cancer Center
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Marcel A. de Dios, PHD
Role: PRINCIPAL_INVESTIGATOR
M.D. Anderson Cancer Center
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University of Texas MD Anderson Cancer Center
Houston, Texas, United States
Countries
Review the countries where the study has at least one active or historical site.
Related Links
Access external resources that provide additional context or updates about the study.
University of Texas MD Anderson Cancer Center website
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2012-1051
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.